"UDENYCA ONBODY Launch"
Device Digest

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI) presentation of UDENYCA® (pegfilgrastim-cbqv), is successfully underway, with a broad distribution of accounts nationwide ordering this innovative device, and patients now accessing its benefits. UDENYCA is a pegfilgrastim biosimilar administered the day after chemotherapy to decrease the incidence of […]

"BioXcel Therapeutics Fast Track Designation"
Digital Health News

BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of BXCL701 in combination with a CPI for the treatment of patients with metastatic small cell […]

Amgen CodeBreaK 101 Study Results
Drug Updates

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC

Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS® (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These results were featured in an oral presentation at the International Association for the Study of […]

Drug Updates

Chemotherapy before surgery can reduce risk of colon cancer recurrence, says Cancer Research UK trial

A recent clinical trial funded by Cancer Research UK has found that administering chemotherapy before surgery can significantly lower the risk of colon cancer recurrence. The FOxTROT trial, led by the University of Birmingham and the University of Leeds, involved 1,053 colon cancer patients from 85 hospitals across the UK, Denmark, and Sweden. The trial […]

Hospital Updates

6-Month-Old Baby successfully treated for eye cancer at Wadia Hospital, Mumbai

A team headed by Dr Suyash Kulkarni, Head , Interventional Radiology, Bai Jerbai Wadia Hospital For Children successfully performed its 1st ophthalmic artery chemotherapy procedure on a 6-month-old baby boy with eye cancer to save his eyes. Ophthalmic artery chemotherapy is a very specialized procedure done by intervention radiologist. In this procedure, anticancer drug is […]